Peer Review reports

From: Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial protocol

Original Submission
19 Oct 2022	Submitted	Original manuscript
23 Nov 2022	Author responded	Author comments - Yulin Leng
Resubmission - Version 2
23 Nov 2022	Submitted	Manuscript version 2
25 Nov 2022	Author responded	Author comments - Yulin Leng
Resubmission - Version 3
25 Nov 2022	Submitted	Manuscript version 3
Publishing
28 Nov 2022	Editorially accepted
22 Dec 2022	Article published	10.1186/s12906-022-03813-9

You can find further information about peer review here.

Back to article page